AZURRX BIOPHARMA INC's ticker is AZRX and the CUSIP is 05502L105. A total of 19 filers reported holding AZURRX BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $21,000 | -22.2% | 30,000 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $27,000 | +58.8% | 30,000 | 0.0% | 0.01% | -14.3% |
| Q1 2020 | $17,000 | -34.6% | 30,000 | +20.0% | 0.01% | +75.0% |
| Q4 2019 | $26,000 | -89.8% | 25,000 | -83.3% | 0.00% | -90.0% |
| Q2 2019 | $255,000 | -29.8% | 150,000 | 0.0% | 0.04% | -42.9% |
| Q1 2019 | $363,000 | +99.5% | 150,000 | 0.0% | 0.07% | +52.2% |
| Q4 2018 | $182,000 | -52.8% | 150,000 | 0.0% | 0.05% | -11.5% |
| Q3 2018 | $386,000 | -12.3% | 150,000 | +9.3% | 0.05% | -21.2% |
| Q2 2018 | $440,000 | +69.9% | 137,197 | +66.3% | 0.07% | +69.2% |
| Q1 2018 | $259,000 | -13.7% | 82,500 | 0.0% | 0.04% | +8.3% |
| Q4 2017 | $300,000 | +20.5% | 82,500 | +32.0% | 0.04% | +9.1% |
| Q3 2017 | $249,000 | -11.7% | 62,500 | -10.7% | 0.03% | +43.5% |
| Q2 2017 | $282,000 | – | 70,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDMOND DE ROTHSCHILD HOLDING S.A. | 10,000 | $28,000 | 0.00% |